Background The positivity of QuantiFERON–TB Gold In–Tube test (QFT-G IT) may means
the diagnosis of latent tuberculosis (TB), may persists after chemoprophylaxis or may …

Background Tuberculosis is a major infectious problem during anti-TNF treatments in
tuberculosis prevalent countries. BCG vaccine may influence tuberculosis skin test (TST) …

Background: Screening for latent tuberculosis infection (LTBI) is mandatory in patients
scheduled for treatment with anti-TNFα agents, due to the increased risk of progression to …

Background Long-term treatment of anti-TNF agents in patients with immune mediated
disease can increase the risk of active tuberculosis infection (ATBI) by reactivation of latent …

Background Treatment with an anti-TNF agent can increase the risk of tuberculosis (TB) by
reactivation of latent tuberculosis infection (LTBI) or new infection. Objectives To identify the …

(TST) may not be an optimal test for the diagnosis of latent tuberculosis infection (LTBI) in
patients with rheumatoid arthritis. We would like to contribute to these findings, based on our …

Background The detection of latent TB infection (LTBI) and institution of appropriate
prophylactic therapy is an essential requirement before prescribing biologic disease …

Background The recommendations for detecting latent tuberculosis infection (LTBI) before
antitumour necrosis factor (anti-TNF) therapy are based on the tuberculin skin test (TST) …

Results: In rheumatic patients positive results of QFT IT and TST tests were identified in 15
cases (16.7%) whereas negative results of both tests were detected in 56 cases (62.2%). In …

Biological agents interfering with proinflammatory tumour necrosis factor α (TNFα) signalling
have become an established tool in the treatment of rheumatoid arthritis and other chronic …